GlassScriptPhysician profile
Kenneth Kim
NPI 1154325777
$863.38
in general payments reported to CMS, 2019-2025
15 companies · $46.54 in 2025
The $46.54 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $62.53 · 2021: $72.97 · 2022: $177 · 2023: $227 · 2024: $118 · 2025: $46.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.69 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $157.47 | 2019-2023 | Belbuca |
| Scilex Pharmaceuticals INC. | $50.01 | 2021-2025 | Ztlido |
| Bioventus LLC | $41.21 | 2023 | Durolane |
| Allergan, INC. | $39.93 | 2020 | |
| Redhill Biopharma INC. | $33.08 | 2022-2023 | Talicia, Aemcolo, Movantik |
| Spr Therapeutics, INC | $29.33 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $28.36 | 2025 | Watchman Flx |
| Electronic Waveform Lab, INC. | $26.99 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.51 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.60 | 2020 | |
| Fidia Pharma USA INC. | $19.39 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.50 | 2022 | |
| Grt US Holding, INC. | $14.26 | 2022 | |
| Mdd US Operations, LLC | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.